Upstream Biosciences Inc. (OTCBB: UPBS) (“Upstream” or “the Company”), an emerging leader in the field of genetic diagnostics for cancer and the prediction of drug response, has announced today the appointment of Dr. Brett Casey to its scientific advisory board. Dr. Casey is the Director of the Molecular Genetics Laboratory at British Columbia’s Children’s Hospital.
